Ernexa Therapeutics Inc. Deferred Costs, Noncurrent
Ernexa Therapeutics Inc. (ERNA) had Deferred Costs, Noncurrent of $72.00 thousand as of 2020-12-31, per its 10-K filed 2021-03-11.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredCosts · last filed 2021-03-11
- 2020-12-31: Deferred Costs, Noncurrent $72.00K.
- 2020-09-30: Deferred Costs, Noncurrent $85.00K.
- 2020-06-30: Deferred Costs, Noncurrent $152.00K.
- 2020-03-31: Deferred Costs, Noncurrent $239.00K.
| Period end | Deferred Costs, Noncurrent |
|---|---|
| 2020-12-31 | $72.00K 10-K · filed 2021-03-11 |
| 2020-09-30 | $85.00K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $152.00K 10-Q · filed 2020-08-07 |
| 2020-03-31 | $239.00K 10-Q · filed 2020-05-20 |
| 2019-12-31 | $274.00K 10-K · filed 2021-03-11 |
| 2019-09-30 | $340.00K 10-Q · filed 2019-11-01 |
| 2019-06-30 | $377.00K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $427.00K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $424.00K 10-K · filed 2020-03-19 |
| 2018-09-30 | $470.00K 10-Q · filed 2018-11-09 |
| 2018-06-30 | $541.00K 10-Q · filed 2018-08-06 |
| 2018-03-31 | $627.00K 10-Q · filed 2018-05-11 |
| 2017-12-31 | $775.00K 10-K · filed 2019-03-22 |
| 2017-09-30 | $869.00K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $850.00K 10-Q · filed 2017-08-04 |
| 2017-03-31 | $851.00K 10-Q · filed 2017-05-04 |
| 2016-12-31 | $904.00K 10-K · filed 2018-03-09 |
| 2016-09-30 | $1.05M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $1.19M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $1.30M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $1.33M 10-K · filed 2017-03-09 |
| 2015-09-30 | $1.34M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $1.30M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $1.16M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $1.09M 10-K · filed 2016-03-15 |
| 2014-09-30 | $984.00K 10-Q · filed 2014-11-07 |
| 2014-06-30 | $908.00K 10-Q · filed 2014-08-14 |
| 2014-03-31 | $706.00K 10-Q · filed 2014-05-15 |
| 2013-12-31 | $562.00K 10-K · filed 2015-03-27 |
| 2013-09-30 | $395.00K 10-Q · filed 2013-11-14 |
| 2013-06-30 | $448.00K 10-Q · filed 2013-08-14 |
| 2013-03-31 | $514.00K 10-Q · filed 2013-05-13 |
| 2012-12-31 | $600.00K 10-K · filed 2014-03-31 |
| 2012-09-30 | $711.00K 10-Q · filed 2012-11-09 |
| 2012-06-30 | $745.00K 10-Q · filed 2012-08-14 |
| 2012-03-31 | $931.00K 10-Q · filed 2012-05-11 |
| 2011-12-31 | $1.13M 10-K · filed 2013-03-29 |
| 2011-09-30 | $1.17M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $1.09M 10-Q · filed 2011-08-12 |
| 2010-12-31 | $839.00K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |